**Core Concept**
The patient has decompensated liver cirrhosis with variceal bleeding, a complication of portal hypertension. The preferred treatment modality should aim to control bleeding, prevent recurrence, and manage underlying liver disease.

**Why the Correct Answer is Right**
Endoscopic variceal ligation (EVL) or sclerotherapy is the preferred mode of treatment in this patient. This is because EVL is a highly effective method for controlling variceal bleeding and preventing recurrence. The procedure involves using a specialized endoscope to ligate or tie off the varices, thereby preventing further bleeding. Additionally, EVL is less invasive compared to surgical shunt procedures and can be repeated as needed.

**Why Each Wrong Option is Incorrect**
* **Option A:** Transjugular intrahepatic portosystemic shunt (TIPS) is a valuable option for patients with recurrent variceal bleeding or those who are not responding to endoscopic or pharmacological therapy. However, it is not the first-line treatment for variceal bleeding in compensated liver cirrhosis.
* **Option B:** Pharmacological therapy with vasoconstrictors or beta-blockers may be used as an adjunct to endoscopic therapy or in patients who are not candidates for EVL. However, it is not the preferred mode of treatment for variceal bleeding.
* **Option C:** Surgical shunt procedures, such as portocaval shunt, are generally reserved for patients with severe portal hypertension or those who have failed other treatments. They carry a higher risk of complications and are not the preferred initial treatment for variceal bleeding in compensated liver cirrhosis.

**Clinical Pearl / High-Yield Fact**
It's essential to note that the management of variceal bleeding in liver cirrhosis involves a multidisciplinary approach, including endoscopic, pharmacological, and surgical interventions. The choice of treatment modality depends on the severity of the bleeding, the patient's overall liver function, and the presence of any underlying comorbidities.

**Correct Answer: C. Surgical shunt procedures are generally reserved for patients with severe portal hypertension or those who have failed other treatments.**